United States Next Generation Cancer Diagnostic Devices Market Report 2017

November 2017 | 112 pages | ID: U567FB86C23WEN
QYResearch

Abstracts

In this report, the United States Next Generation Cancer Diagnostic Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest

with sales (volume), revenue (value), market share and growth rate of Next Generation Cancer Diagnostic Devices in these regions, from 2012 to 2022 (forecast).
United States Next Generation Cancer Diagnostic Devices market competition by top manufacturers/players, with Next Generation Cancer Diagnostic Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Roche Holding Ltd.?Switzerland)
• Abbott Laboratories(US)
• Siemens Healthcare(Germany)
• Agilent Technologies Inc(Germany)
• Illumina Inc.(US)
• Becton Dickinson and Co.(US)
• QIAGEN N.V.(Germany)
• Affymetrix Inc.(US)
• Johnson & Johnson(US)
• Thermo Fisher Scientific Inc.(US)
• GE Healthcare(England)
• Life Technologies Corp.(US)
• Luminex Corp.(US)
• Cepheid Inc.(US)
• Allegro Diagnostics Corp.(Brazil)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Next Generation Sequencing
• qPCR & Multiplexing
• Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
• Protein Microarrays
• DNA Microarrays

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Next Generation Cancer Diagnostic Devices for each application, including

• Biomarker Development
• CTC Analysis
• Proteomic Analysis
• Epigenetic Analysis
• Genetic Analysis

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Next Generation Cancer Diagnostic Devices Market Report 2017

1 NEXT GENERATION CANCER DIAGNOSTIC DEVICES OVERVIEW

1.1 Product Overview and Scope of Next Generation Cancer Diagnostic Devices
1.2 Classification of Next Generation Cancer Diagnostic Devices by Product Category
  1.2.1 United States Next Generation Cancer Diagnostic Devices Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Next Generation Cancer Diagnostic Devices Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Next Generation Sequencing
  1.2.4 qPCR & Multiplexing
  1.2.5 Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
  1.2.6 Protein Microarrays
  1.2.7 DNA Microarrays
1.3 United States Next Generation Cancer Diagnostic Devices Market by Application/End Users
  1.3.1 United States Next Generation Cancer Diagnostic Devices Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Biomarker Development
  1.3.3 CTC Analysis
  1.3.4 Proteomic Analysis
  1.3.5 Epigenetic Analysis
  1.3.6 Genetic Analysis
1.4 United States Next Generation Cancer Diagnostic Devices Market by Region
  1.4.1 United States Next Generation Cancer Diagnostic Devices Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Next Generation Cancer Diagnostic Devices Status and Prospect (2012-2022)
  1.4.3 Southwest Next Generation Cancer Diagnostic Devices Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Next Generation Cancer Diagnostic Devices Status and Prospect (2012-2022)
  1.4.5 New England Next Generation Cancer Diagnostic Devices Status and Prospect (2012-2022)
  1.4.6 The South Next Generation Cancer Diagnostic Devices Status and Prospect (2012-2022)
  1.4.7 The Midwest Next Generation Cancer Diagnostic Devices Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Next Generation Cancer Diagnostic Devices (2012-2022)
  1.5.1 United States Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2012-2022)
  1.5.2 United States Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2012-2022)

2 UNITED STATES NEXT GENERATION CANCER DIAGNOSTIC DEVICES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Next Generation Cancer Diagnostic Devices Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Next Generation Cancer Diagnostic Devices Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Next Generation Cancer Diagnostic Devices Average Price by Players/Suppliers (2012-2017)
2.4 United States Next Generation Cancer Diagnostic Devices Market Competitive Situation and Trends
  2.4.1 United States Next Generation Cancer Diagnostic Devices Market Concentration Rate
  2.4.2 United States Next Generation Cancer Diagnostic Devices Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Next Generation Cancer Diagnostic Devices Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES NEXT GENERATION CANCER DIAGNOSTIC DEVICES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Next Generation Cancer Diagnostic Devices Sales and Market Share by Region (2012-2017)
3.2 United States Next Generation Cancer Diagnostic Devices Revenue and Market Share by Region (2012-2017)
3.3 United States Next Generation Cancer Diagnostic Devices Price by Region (2012-2017)

4 UNITED STATES NEXT GENERATION CANCER DIAGNOSTIC DEVICES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Next Generation Cancer Diagnostic Devices Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Next Generation Cancer Diagnostic Devices Revenue and Market Share by Type (2012-2017)
4.3 United States Next Generation Cancer Diagnostic Devices Price by Type (2012-2017)
4.4 United States Next Generation Cancer Diagnostic Devices Sales Growth Rate by Type (2012-2017)

5 UNITED STATES NEXT GENERATION CANCER DIAGNOSTIC DEVICES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Next Generation Cancer Diagnostic Devices Sales and Market Share by Application (2012-2017)
5.2 United States Next Generation Cancer Diagnostic Devices Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES NEXT GENERATION CANCER DIAGNOSTIC DEVICES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Roche Holding Ltd.?Switzerland)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Next Generation Cancer Diagnostic Devices Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Abbott Laboratories(US)
  6.2.2 Next Generation Cancer Diagnostic Devices Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Siemens Healthcare(Germany)
  6.3.2 Next Generation Cancer Diagnostic Devices Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Agilent Technologies Inc(Germany)
  6.4.2 Next Generation Cancer Diagnostic Devices Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Illumina Inc.(US)
  6.5.2 Next Generation Cancer Diagnostic Devices Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Becton Dickinson and Co.(US)
  6.6.2 Next Generation Cancer Diagnostic Devices Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 QIAGEN N.V.(Germany)
  6.7.2 Next Generation Cancer Diagnostic Devices Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Affymetrix Inc.(US)
  6.8.2 Next Generation Cancer Diagnostic Devices Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Johnson & Johnson(US)
  6.9.2 Next Generation Cancer Diagnostic Devices Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Thermo Fisher Scientific Inc.(US)
  6.10.2 Next Generation Cancer Diagnostic Devices Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 GE Healthcare(England)
6.12 Life Technologies Corp.(US)
6.13 Luminex Corp.(US)
6.14 Cepheid Inc.(US)
6.15 Allegro Diagnostics Corp.(Brazil)

7 NEXT GENERATION CANCER DIAGNOSTIC DEVICES MANUFACTURING COST ANALYSIS

7.1 Next Generation Cancer Diagnostic Devices Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Next Generation Cancer Diagnostic Devices Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Next Generation Cancer Diagnostic Devices Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NEXT GENERATION CANCER DIAGNOSTIC DEVICES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Next Generation Cancer Diagnostic Devices Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Next Generation Cancer Diagnostic Devices Sales Volume Forecast by Type (2017-2022)
11.3 United States Next Generation Cancer Diagnostic Devices Sales Volume Forecast by Application (2017-2022)
11.4 United States Next Generation Cancer Diagnostic Devices Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Next Generation Cancer Diagnostic Devices
Figure United States Next Generation Cancer Diagnostic Devices Market Size (K Pcs) by Type (2012-2022)
Figure United States Next Generation Cancer Diagnostic Devices Sales Volume Market Share by Type (Product Category) in 2016
Figure Next Generation Sequencing Product Picture
Figure qPCR & Multiplexing Product Picture
Figure Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) Product Picture
Figure Protein Microarrays Product Picture
Figure DNA Microarrays Product Picture
Figure United States Next Generation Cancer Diagnostic Devices Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Next Generation Cancer Diagnostic Devices by Application in 2016
Figure Biomarker Development Examples
Table Key Downstream Customer in Biomarker Development
Figure CTC Analysis Examples
Table Key Downstream Customer in CTC Analysis
Figure Proteomic Analysis Examples
Table Key Downstream Customer in Proteomic Analysis
Figure Epigenetic Analysis Examples
Table Key Downstream Customer in Epigenetic Analysis
Figure Genetic Analysis Examples
Table Key Downstream Customer in Genetic Analysis
Figure United States Next Generation Cancer Diagnostic Devices Market Size (Million USD) by Region (2012-2022)
Figure The West Next Generation Cancer Diagnostic Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Next Generation Cancer Diagnostic Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Next Generation Cancer Diagnostic Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Next Generation Cancer Diagnostic Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Next Generation Cancer Diagnostic Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Next Generation Cancer Diagnostic Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Next Generation Cancer Diagnostic Devices Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Next Generation Cancer Diagnostic Devices Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Next Generation Cancer Diagnostic Devices Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Next Generation Cancer Diagnostic Devices Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Next Generation Cancer Diagnostic Devices Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Next Generation Cancer Diagnostic Devices Sales Share by Players/Suppliers
Figure 2017 United States Next Generation Cancer Diagnostic Devices Sales Share by Players/Suppliers
Figure United States Next Generation Cancer Diagnostic Devices Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Next Generation Cancer Diagnostic Devices Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Next Generation Cancer Diagnostic Devices Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Next Generation Cancer Diagnostic Devices Revenue Share by Players/Suppliers
Figure 2017 United States Next Generation Cancer Diagnostic Devices Revenue Share by Players/Suppliers
Table United States Market Next Generation Cancer Diagnostic Devices Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Next Generation Cancer Diagnostic Devices Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Next Generation Cancer Diagnostic Devices Market Share of Top 3 Players/Suppliers
Figure United States Next Generation Cancer Diagnostic Devices Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Next Generation Cancer Diagnostic Devices Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Next Generation Cancer Diagnostic Devices Product Category
Table United States Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Region (2012-2017)
Table United States Next Generation Cancer Diagnostic Devices Sales Share by Region (2012-2017)
Figure United States Next Generation Cancer Diagnostic Devices Sales Share by Region (2012-2017)
Figure United States Next Generation Cancer Diagnostic Devices Sales Market Share by Region in 2016
Table United States Next Generation Cancer Diagnostic Devices Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Next Generation Cancer Diagnostic Devices Revenue Share by Region (2012-2017)
Figure United States Next Generation Cancer Diagnostic Devices Revenue Market Share by Region (2012-2017)
Figure United States Next Generation Cancer Diagnostic Devices Revenue Market Share by Region in 2016
Table United States Next Generation Cancer Diagnostic Devices Price (USD/Pcs) by Region (2012-2017)
Table United States Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Type (2012-2017)
Table United States Next Generation Cancer Diagnostic Devices Sales Share by Type (2012-2017)
Figure United States Next Generation Cancer Diagnostic Devices Sales Share by Type (2012-2017)
Figure United States Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2016
Table United States Next Generation Cancer Diagnostic Devices Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Next Generation Cancer Diagnostic Devices Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Next Generation Cancer Diagnostic Devices by Type (2012-2017)
Figure Revenue Market Share of Next Generation Cancer Diagnostic Devices by Type in 2016
Table United States Next Generation Cancer Diagnostic Devices Price (USD/Pcs) by Types (2012-2017)
Figure United States Next Generation Cancer Diagnostic Devices Sales Growth Rate by Type (2012-2017)
Table United States Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Application (2012-2017)
Table United States Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2012-2017)
Figure United States Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2012-2017)
Figure United States Next Generation Cancer Diagnostic Devices Sales Market Share by Application in 2016
Table United States Next Generation Cancer Diagnostic Devices Sales Growth Rate by Application (2012-2017)
Figure United States Next Generation Cancer Diagnostic Devices Sales Growth Rate by Application (2012-2017)
Table Roche Holding Ltd.?Switzerland) Basic Information List
Table Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Sales Growth Rate (2012-2017)
Figure Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Sales Market Share in United States (2012-2017)
Figure Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Revenue Market Share in United States (2012-2017)
Table Abbott Laboratories(US) Basic Information List
Table Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales Growth Rate (2012-2017)
Figure Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Revenue Market Share in United States (2012-2017)
Table Siemens Healthcare(Germany) Basic Information List
Table Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales Growth Rate (2012-2017)
Figure Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales Market Share in United States (2012-2017)
Figure Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Revenue Market Share in United States (2012-2017)
Table Agilent Technologies Inc(Germany) Basic Information List
Table Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales Growth Rate (2012-2017)
Figure Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales Market Share in United States (2012-2017)
Figure Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Revenue Market Share in United States (2012-2017)
Table Illumina Inc.(US) Basic Information List
Table Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales Growth Rate (2012-2017)
Figure Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales Market Share in United States (2012-2017)
Figure Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Revenue Market Share in United States (2012-2017)
Table Becton Dickinson and Co.(US) Basic Information List
Table Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales Growth Rate (2012-2017)
Figure Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales Market Share in United States (2012-2017)
Figure Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Revenue Market Share in United States (2012-2017)
Table QIAGEN N.V.(Germany) Basic Information List
Table QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales Growth Rate (2012-2017)
Figure QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales Market Share in United States (2012-2017)
Figure QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Revenue Market Share in United States (2012-2017)
Table Affymetrix Inc.(US) Basic Information List
Table Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales Growth Rate (2012-2017)
Figure Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales Market Share in United States (2012-2017)
Figure Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson(US) Basic Information List
Table Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales Growth Rate (2012-2017)
Figure Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Revenue Market Share in United States (2012-2017)
Table Thermo Fisher Scientific Inc.(US) Basic Information List
Table Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales Growth Rate (2012-2017)
Figure Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales Market Share in United States (2012-2017)
Figure Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Revenue Market Share in United States (2012-2017)
Table GE Healthcare(England) Basic Information List
Table Life Technologies Corp.(US) Basic Information List
Table Luminex Corp.(US) Basic Information List
Table Cepheid Inc.(US) Basic Information List
Table Allegro Diagnostics Corp.(Brazil) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Next Generation Cancer Diagnostic Devices
Figure Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices
Figure Next Generation Cancer Diagnostic Devices Industrial Chain Analysis
Table Raw Materials Sources of Next Generation Cancer Diagnostic Devices Major Players/Suppliers in 2016
Table Major Buyers of Next Generation Cancer Diagnostic Devices
Table Distributors/Traders List
Figure United States Next Generation Cancer Diagnostic Devices Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Next Generation Cancer Diagnostic Devices Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Next Generation Cancer Diagnostic Devices Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Next Generation Cancer Diagnostic Devices Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Next Generation Cancer Diagnostic Devices Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Next Generation Cancer Diagnostic Devices Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Next Generation Cancer Diagnostic Devices Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Next Generation Cancer Diagnostic Devices Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Next Generation Cancer Diagnostic Devices Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Next Generation Cancer Diagnostic Devices Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Next Generation Cancer Diagnostic Devices Sales Volume Share Forecast by Region (2017-2022)
Figure United States Next Generation Cancer Diagnostic Devices Sales Volume Share Forecast by Region (2017-2022)
Figure United States Next Generation Cancer Diagnostic Devices Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources